| Bioactivity | Miglustat (N-Butyldeoxynojirimycin) is an orally active ceramide glucosyltransferase inhibitor. Miglustat can be used for the research of type I gaucher disease[1][2]. |
| Name | Miglustat |
| CAS | 72599-27-0 |
| Formula | C10H21NO4 |
| Molar Mass | 219.28 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Miglustat. Mother To Baby | Fact Sheet, Organization of Teratology Information Specialists (OTIS), 1 April 2021. [2]. Neal J Weinreb, et al. Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol. 2005 Nov;80(3):223-9. |
Miglustat
CAS: 72599-27-0 F: C10H21NO4 W: 219.28
Miglustat (N-Butyldeoxynojirimycin) is an orally active ceramide glucosyltransferase inhibitor. Miglustat can be used fo
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.